Sunitinib in Treating Patients With Kidney Cancer That Has Spread to the Brain
Institut Claudius Regaud
Institut Claudius Regaud
M.D. Anderson Cancer Center
Alliance for Clinical Trials in Oncology
Mayo Clinic
Beijing Biotech
Parabilis Medicines, Inc.
St. Justine's Hospital
Actuate Therapeutics Inc.
NRG Oncology
National Institutes of Health Clinical Center (CC)
Assistance Publique - Hôpitaux de Paris
Hoffmann-La Roche
Orano Med LLC
M.D. Anderson Cancer Center
Stanford University
Centre Oscar Lambret
University Hospital Heidelberg
M.D. Anderson Cancer Center
Baptist Health South Florida
Baptist Health South Florida
Memorial Sloan Kettering Cancer Center
Monteris Medical
Essen Biotech
Essen Biotech
Insel Gruppe AG, University Hospital Bern
M.D. Anderson Cancer Center
Massachusetts General Hospital
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
Melanoma Institute Australia
Turning Point Therapeutics, Inc.
Massive Bio, Inc.
M.D. Anderson Cancer Center
GT Medical Technologies, Inc.
Hadassah Medical Organization
Emory University
Hellenic Cooperative Oncology Group
Assistance Publique - Hôpitaux de Paris
Plus Therapeutics
University of California, San Francisco
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Henry Ford Health System
MedSIR
NRG Oncology
Attikon Hospital
Grupo Español Multidisciplinar de Melanoma
Thomas Jefferson University
GT Medical Technologies, Inc.
Phost'In Therapeutics
Cedars-Sinai Medical Center